Skip to main content
. Author manuscript; available in PMC: 2023 Jan 3.
Published in final edited form as: Vaccine. 2021 Nov 19;40(1):133–140. doi: 10.1016/j.vaccine.2021.11.036

Figure 3. IC50.

Figure 3.

IC50 (mol/L) of sera samples from mice immunized with E. coli or CHO rPvs48/45 in each indicated adjuvant, collected at day 60 (A, B and C). Comparisons between CHO-rPvs48/45 and E. coli rPvs48/45 protein within each adjuvant are shown. Mann-Whitney analysis shows significant differences between E. coli and CHO proteins formulated in Alhydrogel (p=0.0079) and GLA-SE (p=0.0286). (D and E) comparison among adjuvants to each rPvs48/45 protein. Dunn’s multiple comparison tests showed significant differences for E. coli protein (D) (*p<0.05), but not for CHO protein (E). Bar corresponds to the median of each subgroup.